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STAT5A Promotes Adipogenesis in Nonprecursor Cells
and Associates With the Glucocorticoid Receptor
During Adipocyte Differentiation
Z. Elizabeth Floyd and Jacqueline M. Stephens
The differentiation of adipocytes is regulated by the
activity of a variety of transcription factors, including
peroxidase proliferator-activated receptor (PPAR)-
and C/EBP. Our current study demonstrates that ec-
topic expression of STAT5A, such as that of PPAR- and
C/EBP, promotes adipogenesis in two nonprecursor
fibroblast cell lines. Using morphologic and biochemical
criteria, we have demonstrated that STAT5A and the
combination of STAT5A and STAT5B are sufficient to
induce the expression of early and late adipogenic
markers in BALB/c and NIH-3T3 cells. Yet, the ectopic
expression of STAT5B alone does not induce the ex-
pression of adipocyte genes, but enhances the induction
of these genes in cells also expressing STAT5A. This
finding suggests that STAT5A and STAT5B do not func-
tion identically in adipocytes. In addition, these studies
demonstrate that the phosphorylation of STAT5 pro-
teins may play a role in adipogenesis. Moreover, we have
shown that STAT5A is associated with the glucocorti-
coid receptor during adipogenesis in a highly regulated
manner. Diabetes 52:308–314, 2003
A
dipocytes are highly specialized cells that play a
major role in energy homeostasis in vertebrate
organisms. Obesity is the primary disease of fat
cells and the most common metabolic disorder
in the industrial world. Obesity affects 30% of the adult
population in the U.S. and is a major risk factor for the
development of type 2 diabetes. Recent studies suggest
that obesity and its related disorders may be linked to a
breakdown in the regulatory mechanisms that control the
expression of metabolic genes in adipocytes. Significant
advances toward understanding these regulatory pro-
cesses have been made by the identification of transcrip-
tion factors that regulate the differentiation of fat cells and
are involved in the induction and maintenance of adipo-
cyte gene expression.
Signal transducers and activators of transcription
(STATs) are a family of latent transcription factors that
reside in the cytoplasm of resting cells. In response to
various stimuli, STATs become tyrosine phosphorylated
and translocate to the nucleus, where they mediate tran-
scriptional regulation. STATs can be rapidly activated to
regulate gene expression and represent a relatively unex-
plored paradigm in the transcriptional regulation of fat
cells (1). Numerous studies suggest that STATs are in-
volved in regulation of tissue-specific genes. Transgenic
knockout experiments have revealed crucial roles for each
known mammalian STAT (1), and cell-specific functions
for STAT family members have been identified (2). How-
ever, the specificity of STAT activation and function is not
completely understood. Specificity is determined, at least
in part, by the receptor and the specific STAT protein.
Other conditions such as serine phosphorylation, dimer
composition, and the presence of other proteins associ-
ated with the STAT dimers may also confer STAT speci-
ficity (1). Moreover, STATs have additional levels of
complexity. Two STAT family members, STAT5A and
STAT5B, are highly related but are encoded by two
separate genes (3). Murine STAT5A and STAT5B have a
96% sequence similarity, with the major difference occur-
ring at the COOH-terminus, where the final eight residues
are nonconserved. Also, STAT5B is 12 residues shorter
than STAT5A. Interestingly, STAT5A and STAT5B have
been shown to have both essential and nonessential roles
in cytokine responses (4).
A number of studies suggest that STAT5 proteins may
have an important role in fat cells. We have shown that
STAT5A and STAT5B proteins are highly induced during
adipocyte differentiation and that the expression of STAT5
proteins correlates with lipid accumulation and the ex-
pression of PPAR- and C/EBP (5–7). STAT5 antisense
oligonucleotides have been shown to inhibit the growth
hormone (GH)-dependent differentiation of 3T3-F442A
preadipocytes (8). In addition, the expression of a domi-
nant-negative STAT5A in 3T3-L1 cells attenuates lipid
accumulation (9). Animal studies also suggest that
STAT5A and STAT5B may be important mediators of fat
cell development (4). Transgenic knockout animals lack-
ing either the STAT5A or STAT5B gene have a reduction in
fat pad size, but mice lacking both STAT5A and STAT5B
have fat pads that are approximately one-fifth the size of
wild-type mice (4). Moreover, studies in these animals
suggest that the lipolytic actions of GH involve STAT5
proteins (10).
The glucocorticoid receptor (GR) has also been shown
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to act as a transcriptional co-activator of STAT5 and
enhance STAT5 dependent transcription (11). In the GR
pathway, the receptor interacts with its steroid hormone
ligand in the cytoplasm and undergoes an allosteric
change that enables the hormone receptor complex to
bind to a specific DNA-responsive element (glucocorticoid
response element) and modulate transcription (12). Glu-
cocorticoid excess frequently results in obesity, insulin
resistance, glucose intolerance, and hypertension. Tissue
sensitivity to glucocorticoids is regulated by the expres-
sion of GR isoforms and 11-hydroxysteroid dehydroge-
nase type I–mediated intracellular synthesis of active
cortisol from inactive cortisone. In mammary cells, GR can
bind STAT5A and STAT5B homodimers and heterodimers
(13). Interestingly, this complex does not appear to inter-
act with glucocorticoid response elements or STAT5 bind-
ing sites within promoters. For example, when GR
interacts with STAT5 proteins to regulate the -casein
promoter, binding occurs at sites that do not function in
the absence of active STAT5 (14). In addition, STAT5 can
inhibit GR regulation of transcription (15).
In this study, we examined the adipogenic capabilities
of STAT5 proteins by ectopic expression in nonprecursor
fibroblast (BALB/c and NIH-3T3) cell lines. This approach
has been useful in examining other adipocyte transcription
factors (16–20). In those experiments, ectopic expression
of these transcription factors in nonadipogenic precursor
cells resulted in the formation of lipid accumulating cells.
Fibroblast cell lines do not normally undergo adipogene-
sis, even with the addition of the appropriate hormonal
stimuli, and are significantly different from 3T3-L1 preadi-
pocytes, which undergo adipogenesis with the same con-
ditions (21). Our results clearly demonstrate that STAT5A
is sufficient to confer adipogenesis in two fibroblast cell
lines. We observed that ectopic expression of STAT5A
alone, or in the presence of STAT5B, is adipogenic in
BALB/c and NIH-3T3 cells, as judged by marker gene
expression and lipid accumulation. Moreover, the adipo-
genesis of these cells occurs in the absence of thiazo-
lidinediones (TZDs). STAT5B alone, unlike STAT5A, is not
adipogenic. However, the presence of STAT5B enhances
the adipogenic capabilities of STAT5A. Our studies also
suggest that the tyrosine phosphorylation of STAT5 ap-
pears to be involved in the ability of STAT5A to confer
adipogenesis. In addition, we have shown that association
of STAT5A with the GR is highly regulated during differ-
entiation and may contribute to the ability of STAT5
proteins to regulate adipocyte gene expression.
RESEARCH DESIGN AND METHODS
Materials. Dulbecco’s modified Eagle’s medium (DMEM) was purchased
from Life Technologies. Bovine and fetal bovine serum (FBS) were obtained
from Sigma and Life Technologies, respectively. Murine tumor necrosis factor
(TNF)- was purchased from Biosource International. The non-phospho STAT
antibodies were monoclonal IgGs purchased from Transduction Laboratories
or polyclonal IgGs from Santa Cruz. A highly phospho-specific polyclonal
antibody for STAT5 (tyrosine [Y694]) was purchased from Upstate Biotechnol-
ogies. Anti–PPAR- was a mouse monoclonal (Santa Cruz). Anti-GR was a
rabbit polyclonal (Santa Cruz). Darglitizone was generously provided by Pfizer
(Groton, CT).
Cell culture. Murine 3T3-L1 preadipocytes were plated and grown to 2 days
post-confluence in DMEM with 10% bovine serum. Medium was changed every
48 h. Cells were induced to differentiate by changing the medium to DMEM
containing a standard induction cocktail of 10% FBS, 0.5 mmol/l 3-isobutyl-1-
methylxanthine, 1 mol/l dexamethasone, and 1.7 mol/l insulin (MIX,
dexamethasone, insulin [MDI]). After 48 h, this medium was replaced with
DMEM supplemented with 10% FBS, and cells were maintained in this
medium. NIH-3T3 and BALB/c fibroblast cell lines were obtained from the
American Type Culture Collection (ATCC). Fibroblast cell lines ectopically
expressing STAT5 genes were induced to differentiate with the standard
(MDI) induction cocktail, in the presence or absence of 2.5 mol/l dargliti-
zone.
Retroviral-mediated transfection in nonprecursor cells. Retroviral-
mediated stable expression of pBabe parental vector, pBabePPAR-2,
pBabeSTAT5A, pBabeSTAT5B, and pBabeSTAT5A/B was generated in NIH-
3T3 and BALB/c cell lines. Recombinant retroviruses were produced as
described (22,23). Briefly, BOSC-23 packaging cells were transiently trans-
fected with 20 g of each retroviral construct. STAT5A/B combination
transfections were carried out using 10 g of each construct. At 8 and 24 h
after transfection, the media were changed to DMEM and 10% calf serum, and
at 48 h, the virus-containing media were collected, filtered (0.45 m), and
supplemented with 4 g/ml polybrene. Target cells were incubated for 10 h
with the retrovirus-containing solution. Puromycin (2.5 g/ml) selection was
initiated at 48 h and continued for 2 weeks.
Preparation of whole-cell extracts. Cell monolayers were rinsed with PBS
and harvested in a nondenaturing buffer containing 150 mmol/l NaCl, 10
mmol/l Tris, pH 7.4, 1 mmol/l EGTA, 1 mmol/l EDTA, 1% Triton X-100, 0.5%
Nonidet P-40, 1 mol/l phenylmethylsulfonyl fluoride, 1 mol/l pepstatin, 50
trypsin inhibitory milliunits of aprotinin, 10 mol/l leupeptin, and 2 mmol/l
sodium vanadate. Samples were extracted for 30 min on ice and centrifuged
at 15,000 rpm at 4°C for 15 min. Supernatants containing whole-cell extracts
were analyzed for protein content using a BCA kit (Pierce) according to the
manufacturer’s instructions.
Immunoprecipitations of GR from adipocyte extracts. Cells were har-
vested under nondenaturing conditions, and the protein content of the
whole-cell extracts was analyzed as described above. Protein extracts (1
mg/sample) were preincubated with protein A-Sepharose (RepliGen), and the
resulting supernatant was incubated with polyclonal anti-GR antibody (2 g)
for 1 h at 4°C followed by incubation with protein A-Sepharose for an
additional hour. The beads were rinsed twice with PBS, and immunoprecipi-
tates were analyzed by SDS-PAGE followed by Western blotting with either
STAT5A or GR antibodies.
Oil Red-O staining. Oil Red-O staining was performed as described by Green
and Kehinde (21).
Gel electrophoresis and immunoblotting. Proteins were separated in 7.5%
polyacrylamide (National Diagnostics) gels containing SDS according to
Laemmli (24) and transferred to nitrocellulose (Bio-Rad) in 25 mmol/l Tris, 192
mmol/l glycine, and 20% methanol. After transfer, the membrane was blocked
in 4% milk for 1 h at room temperature. Results were visualized with
horseradish peroxidase–conjugated secondary antibodies (Sigma) and en-
hanced chemiluminescence (Pierce).
RNA analysis. Total RNA was isolated from cell monolayers with TriZOL
(Invitrogen) according to the manufacturer’s instructions, with minor modi-
fications. For Northern blot analysis, 20 g total RNA was denatured in
formamide and electrophoresed through a formaldehyde-agarose gel. The
RNA was transferred to Zeta Probe-GT (Bio-Rad), cross-linked, hybridized,
and washed as previously described (25). Probes were labeled by random
priming using the Klenow Fragment (Promega) and [32P]dATP (Perkin
Elmer, Life Sciences).
RESULTS
To assess the role of STAT5 in adipogenesis, we generated
a series of stable cell lines that ectopically express STAT5
proteins. We used retroviral-mediated transfection of non-
precursor fibroblast cells (BALB/c and NIH-3T3) to pro-
duce cell lines containing the pBabe vector alone,
pBabeSTAT5A, pBabeSTAT5B, or the pBabe STATs 5A
and 5B (STAT5A/B) expression vectors in combination. To
test our hypothesis that STAT5 proteins are involved in
adipogenesis, BALB/c cells ectopically expressing STAT5
genes were induced to differentiate at 2 days after conflu-
ence with the standard differentiation cocktail. Adipogen-
esis was judged by morphologic and biochemical criteria.
As shown in Fig. 1, we assessed the adipogenesis of STAT5
BALB/c stable cell lines by examining the expression of
PPAR-, C/EBP, aP2, and glycerol phosphate dehydroge-
nase (GPD). Cells were induced to differentiate in the
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absence or presence of darglitizone, and total RNA was
isolated at the indicated times. Darglitizone (TZD) was
added to ensure activation of any PPAR- expressed in the
BALB/c or NIH-3T3 stable cell lines. Previous studies have
shown that exogenous activators of PPAR- are necessary
to obtain significant levels of adipogenesis in nonprecur-
sor cell lines (18). As shown in Fig. 1A, we observed an
induction in PPAR- mRNA in STAT5B cells at 3 days after
the initiation of differentiation. Yet, the induction of
PPAR- mRNA occurred at only 2 days after initiation of
differentiation in STAT5A cells and occurred within 1 day
in STAT5A/B cells. A similar pattern was observed for the
induction of C/EBP mRNA (Fig. 1B). In addition to
examining two adipogenic transcription factors, PPAR-
and C/EBP, we examined the expression of aP2, a
fat-specific lipid binding protein. As shown in Fig. 1C, the
induction of aP2 mRNA occurred in STAT5B cells at day 3
and was expressed in a TZD-dependent manner. In
STAT5A cells, aP2 mRNA was induced at day 2 in a
TZD-dependent manner, and in STAT5A/B cells, this
mRNA was induced at day 1 in a similar manner. Interest-
ingly, the expression of aP2 in STAT5B cells always
depended on the presence of TZD. Yet, in 5A cells or 5A/5B
cells, the expression of aP2 mRNA was independent of
TZD in the later stages of adipogenesis. The expression of
GPD, a late marker of adipogenesis, was induced 3 days
after the initiation of differentiation in STAT5A cells and at
2 days after initiation of differentiation in STAT5A/B cells
in the presence of TZD. However, GPD expression was
independent of TZDs at the later stages of differentiation in
STAT5A/B cells (days 5 and 6). GPD mRNA was never
induced in 5B cells (data not shown).
The adipogenesis of BALB/c cells ectopically expressing
STAT5 genes was also assessed by staining for neutral
lipids. BALB/c cell lines were induced to differentiate in
the absence or presence of darglitizone and subjected to
Oil Red-O staining 96 h after the initiation of differentia-
tion. As shown in Fig. 2, the presence of STAT5A alone or
STAT5A and STAT5B in combination resulted in a substan-
tial increase in Oil Red-O staining. We were able to detect
some lipid accumulation in cells containing an “empty”
vector or STAT5B in the presence of a TZD. However,
there was no significant difference in Oil Red-O staining in
these two cell types. In addition, the increased lipid
accumulation observed in STAT5A cells and STAT5A/B
cells was independent of TZDs.
The adipogenic capabilities of PPAR-2 and STAT5
proteins were compared by isolating RNA from BALB/c
cells that stably expressed vector, PPAR-2, STAT5A,
STAT5B, or STATs 5A and 5B. Each cell line was induced
to differentiate in the absence or presence of darglitizone
(TZD), and total RNA and whole-cell extracts were iso-
lated 120 h later. The expression of adipsin, a late marker
fat-specific gene, was examined by Northern blot analysis.
As shown in Fig. 3A, adipsin mRNA was highly induced in
PPAR-2, STAT5A, and STAT5A/B cells in the absence of
TZD. In addition, adipsin mRNA was expressed at substan-
tially lower levels in vector and 5B cells. The expression of
adipsin has been shown to be repressed by TZDs (26).
Whole-cell extracts were also analyzed for the expres-
sion of PPAR-2 and STAT5A by Western blot analysis and
compared with the levels of protein expression in 3T3-L1
adipocytes. As shown in Fig. 3B, PPAR- protein is readily
detectable in all samples except the vector. In the
PPAR-2 cells, there are three types of PPAR- proteins:
PPAR-1, PPAR-2, and the ectopically expressed PPAR-
2. The ectopic PPAR-2 protein migrates slowest, and the
expression of endogenous PPAR-2 and PPAR-1 is in-
duced in these cells, as we also observed in cells ectopi-
cally expressing STAT5 genes. The levels of PPAR- in the
BALB/c cells are comparable to the level of PPAR- found
FIG. 1. Induction of adipogenic markers in BALB/c STAT5B, STAT5A,
and STAT5A/B cells. Total RNA was isolated at the indicated time
points, in days, after the induction of differentiation in the absence ()
or presence () of 2.5 mol/l darglitizone (TZD). Total RNA (15 g)
was electrophoresed, transferred to nylon, and subjected to Northern
blot analysis for marker gene expression. -Actin was included as a
loading control. This was a representative experiment independently
performed two times.
FIG. 2. Oil Red-O staining of neutral lipids in BALB/c cell lines.
Monolayers of BALB/c cells (vector, STAT5A, STAT5B, or STAT5A/B)
were subjected to Oil Red-O staining at 96 h after exposure to the MDI
differentiation cocktail. A– D were maintained in the absence of TZDs
(TZD). E– H were maintained in the presence of 2.5 mol/l dargliti-
zone (TZD). This was a representative experiment independently
performed two times.
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in 3T3-L1 adipocytes (Fig. 3B). The expression of STAT5A
protein is detectable in vector and 5B cells, but the
expression of this protein is induced in STAT5A cells and
STAT5A/B cells. Also, the expression of STAT5A is ele-
vated in PPAR-2 cells that were exposed to TZD treat-
ment.
Because background levels of adipogenesis were ob-
served in the BALB/c cells (Fig. 2E), we also examined the
effect of ectopically expressed STAT5 genes in NIH-3T3
cells. The expression of various adipocyte markers was
examined in NIH-3T3 cell lines ectopically expressing
vector, STAT5A, STAT5B, or both STATs 5A and 5B. As
shown in Fig. 4A, ectopic expression of STAT5A alone or
STAT5A/B induced PPAR- mRNA expression. However,
ectopic expression of STAT5B was insufficient to induce
PPAR- mRNA in the NIH-3T3 cell lines above levels
observed in vector cells. The induction of aP2 mRNA was
slightly increased in a TZD-dependent manner in vector
and 5B cells. However, there was a substantial induction
of aP2 mRNA in STAT5A and STAT5A/B cells. Two late
markers of adipogenesis, GPD and adipsin, were undetect-
able in vector or 5B cells. However, GPD was induced in a
TZD-dependent manner in 5A and 5A/B cells, and adipsin
was also significantly induced in these cells. Moreover,
expression of GLUT4, the insulin-sensitive glucose trans-
porter, was induced in a TZD-dependent manner in
STAT5A and STAT5A/B cells. As an additional indicator of
adipogenesis, we measured PPAR- protein levels in the
NIH-3T3 cell lines. As shown in Fig. 4B, STAT5A or
STAT5A/B cells induce expression of PPAR-, whereas
STAT5B alone does not support PPAR- expression.
To study how STAT5 proteins are acting to influence the
development of adipocytes, we examined the tyrosine
phosphorylation of STAT5 during 3T3-L1 differentiation.
These preadipocytes have the ability to differentiate into
adipocytes that accumulated lipid, are insulin sensitive,
and have the endocrine properties of native adipocytes.
Whole-cell extracts were isolated over a time course of
differentiation in 3T3-L1 cells and examined for STAT5
phosphorylation with a phospho-specific antibody that
recognizes STAT5A and STAT5B when tyrosine694 is phos-
phorylated. As shown in Fig. 5A, STAT5 proteins were
tyrosine-phosphorylated early during adipogenesis and
before the expression of PPAR-. The phosphorylation of
both STATs 5A and 5B was confirmed by immunoprecipi-
FIG. 3. The expression of adipsin mRNA and PPAR- proteins in
BALB/c stable cells. A: Total RNA was isolated 120 h after the induction
of differentiation in the absence (TZD) or presence (TZD) of 2.5
mol/l darglitizone. Total RNA (15 g) was electrophoresed, trans-
ferred to nylon, and subjected to Northern blot analysis for adipogenic
marker expression. -Actin was included as a loading control. B:
Whole-cell extracts were prepared at 120 h after induction of differ-
entiation in the absence () or presence () of 2.5 mol/l darglitizone.
Then, 100 g of each extract was separated by SDS-PAGE, transferred
to nitrocellulose, and subjected to Western blot analysis. The detec-
tion system was horseradish peroxidase–conjugated secondary anti-
bodies (Sigma) and enhanced chemiluminescence (Pierce). Whole-cell
extracts from fully differentiated 3T3-L1 adipocytes (3T3-L1 Ad.) was
included for comparison of protein expression level, and STAT3 was
included as a loading control. The BALB/c cell lines are vector alone
(vector), PPAR-2, STAT5A (5A), STAT5B (5B), and STAT5A/B (5A/
B). This was a representative experiment independently performed
two times.
FIG. 4. Expression of adipogenic markers in NIH-3T3 cells ectopically
expressing STAT5A, STAT5B, or STAT5A/B. A: Total RNA was isolated
120 h after induction of differentiation in the absence () or presence
() of 2.5 mol/l darglitizone. Total RNA (15 g) was electrophoresed,
transferred to nylon, and subjected to Northern blot analysis for
adipogenic marker expression. -Actin was included as a loading
control. The NIH-3T3 cell lines are vector alone (vector), STAT5A
(5A), STAT5B (5B), and STAT5A/B (5A/B). B: Whole-cell extracts were
prepared at 120 h after induction of differentiation in the absence ()
or presence () of 2.5 mol/l darglitizone. Samples were processed,
and results were visualized as described in the Fig. 3 legend. PPAR-1
and PPAR-2 were not resolved. This was a representative experiment
independently performed three times.
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tation with STAT5 antibodies and immunoblotting with an
anti-phosphotyrosine antibody (data not shown). These
results suggest that the tyrosine phosphorylation of STAT5
proteins has a role in adipogenesis. To address this
question, we induced the STAT5A/B BALB/c cells to
differentiate under conditions where a component of the
induction cocktail was missing. We have previously shown
that methyl-isobutyl-xanthine (MIX), insulin, or dexameth-
asone do not induce the tyrosine phosphorylation of
STAT5 proteins in these cells (27). However, FBS treat-
ment results in the tyrosine phosphorylation and nuclear
translocation of STAT5 proteins, likely due to the presence
of GH in FBS (27). Previous studies have demonstrated
that MIX, DEX, and FBS are required for complete adipo-
genesis of 3T3-L1 cells (16) and nonprecursor cells ectopi-
cally expressing PPAR- or C/EBPs (17–20). Therefore, we
examined the requirement of components of the induction
cocktail (FBS, MIX, DEX, and insulin) in the differentiation
of STAT5A/B BALB/c cells. The results in Fig. 5B demon-
strate that the standard induction cocktail resulted in the
induction of PPAR- expression in STAT5A/B BALB/c
cells. Yet, in the absence of MIX, DEX, or FBS, these cells
did not express PPAR- protein. However, if FBS was
replaced with GH in 1% calf serum, the ability of STAT5A/B
BALB/c cells to undergo adipogenesis and express PPAR-
was restored. This regulation of PPAR- was identical in
STAT5A BALB/c cells (data not shown).
Finally, we examined the interaction of STAT5A with
GR. We chose to examine GR because it is highly associ-
ated with obesity and because the GR has been previously
shown to associate with STAT5 in other cell types (11,13).
In addition, the requirement of dexamethasone for expres-
sion of PPAR- in the STAT5A/B BALB/c cells suggests a
role for GR in STAT5-mediated adipogenesis. To deter-
mine whether GR and STAT5A interact during adipogene-
sis, we harvested whole-cell extracts at various times
during adipogenesis and performed Western blot analysis
on whole-cell extracts as well as lysates from immunopre-
cipitations carried out against GR. As shown in Fig. 6A, GR
levels are not regulated during adipogenesis, whereas
STAT5A levels increase at 48 h after the initiation of
differentiation. The results from immunoprecipitation ex-
periments with anti-GR indicate that STAT5A associates
with GR at 72 h after the initiation of differentiation. This
interaction is maintained at 96, 120, and 144 h after the
initiation of differentiation, when cells are fully differenti-
FIG. 5. The activation of STAT5 proteins occurs early in adipogenesis
and is associated with an induction of PPAR- expression. A: Whole-
cell extracts were harvested at the indicated time points after induc-
tion of differentiation (hours after MDI) in 3T3-L1 preadipocytes.
Then, 100 g of each extract was analyzed by SDS-PAGE, followed by
transfer to nitrocellulose and detection using enhanced chemilumines-
cence (Pierce). Tyrosine (Y694)-phosphorylated STAT5 (STAT5PY)
was detected using a phospho-specific polyclonal antibody. B: Whole-
cell extracts were harvested at 96 h after the addition of the standard
induction cocktail (MDI) or cocktails that lacked one component of the
induction cocktail, as indicated at the top of the figure. Additional
extracts were harvested after incubation with the standard MDI
cocktail in the presence of 1% calf serum instead of FBS (FBS) or 1%
calf serum plus GH (FBS, GH). Extracellular-regulated kinase
(ERK)-1/2 expression is included as a loading control. Samples were
processed and results were visualized as described in the Fig. 4 legend.
This was a representative experiment independently performed three
times.
FIG. 6. The association of STAT5A with the GR is highly regulated
during adipogenesis of 3T3-L1 cells. A: Whole-cell extracts were har-
vested at the indicated time points after addition of the MDI differen-
tiation cocktail to 3T3-L1 preadipocytes (hours post-MDI) and stored
at 80°C until all of the samples were collected. Protein levels were
quantified with the BCA kit (Pierce), and an equal amount of each
extract was analyzed as whole-cell extracts (WCE) or immunoprecipi-
tated (IP GR) with polyclonal anti-GR (Santa Cruz). The GR was
detected using the polyclonal anti-GR antibody (Santa Cruz). STAT5A
was detected using a polyclonal anti-STAT5A (Santa Cruz). B: Whole-
cell extracts were isolated from 3T3-L1 preadipocytes (PA) that were
pretreated for 15 min with 1 nmol/l TNF- before the addition of the
differentiation cocktail (MDI) at the 0 time point. Fresh TNF- was
added every 24 h. The samples were analyzed as described above. This
was a representative experiment independently performed three
times.
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ated. Interestingly, this association was undetectable in
confluent preadipocytes (time 0) or in the early stages of
adipogenesis. To further examine the role of STAT5A/GR
association during adipogenesis, confluent 3T3-L1 preadi-
pocytes were induced to differentiate in the presence of
TNF-. TNF- is known to inhibit adipogenesis (25). The
results in Fig. 6B demonstrate that the STAT5A-GR inter-
action that occurs in the later stages of adipogenesis is
inhibited by TNF-. Furthermore, the levels of both GR
and STAT5A decline in the presence of TNF-.
DISCUSSION
These studies demonstrate that STAT5A promotes adipo-
genesis in nonprecursor cells. Moreover, the adipogenesis
of STAT5A cells or STAT5A/B cells was TZD independent,
suggesting these cells are capable of making an endoge-
nous PPAR- ligand. Our results also indicate that STAT5A
is sufficient to induce adipogenesis in nonprecursor cells,
and this adipogenesis is accompanied by an induction of
PPAR- and C/EBP in BALB/c cells. Although PPAR- is
expressed at comparable levels in the BALB/c STAT5B
cells, STAT5B is not adipogenic on its own (Figs. 1–4) but
does enhance the adipogenic properties of STAT5A (Fig.
1A– D). STAT5A differs from STAT5B by eight amino acids
at the COOH-terminus, and our results suggest that the
COOH-terminal regions of STAT5A and STAT5B confer
separate roles for these proteins in adipogenesis.
It is known that PPAR- promotes adipogenesis in
C/EBP-deficient cells, yet C/EBP cannot promote adi-
pogenesis in the absence of PPAR- (28). These recent
findings suggest that C/EBP and PPAR- participate in a
single pathway of fat cell development, with PPAR- being
the proximal effector of adipogenesis (28). We surmise
that STAT5 proteins participate in this identified pathway
of fat cell development and hypothesize it is likely that
STAT5A is an early effector of adipogenesis. This is
supported by our data demonstrating that ectopic STAT5A
expression results in the induction of PPAR- expression
in both BALB/c and NIH-3T3 fibroblasts (Figs. 1, 3, and 4)
as well as in the early activation of STAT5 preceding the
expression of PPAR- in 3T3-L1 adipocytes (Fig. 5A). The
ability of STAT5A to induce adipogenesis in nonprecursor
cells may be mediated by its ability to directly regulate
PPAR- expression. Alternatively, the role of STAT5A in
regulating adipogenesis could be mediated by its associa-
tion with GR or other unidentified co-activators.
Interestingly, STAT5A and GR can associate in NIH-3T3
fibroblasts (13), but we have shown these two transcrip-
tion factors are not associated in 3T3-L1 preadipocytes
(Fig. 6A). The association of STAT5A and GR occurs late
in adipogenesis, coincident with increasing levels of
STAT5A, and may have an inhibitory role because STAT5
has been shown to inhibit GR-mediated regulation of
transcription in other cell types (15). It seems unlikely that
the interaction of STAT5A with GR depends on the con-
centration of STAT5A because NIH-3T3 and 3T3-L1 have
similar levels of STAT5A expression (data not shown).
Hence, we hypothesize that other factors contribute to the
GR/STAT5A association that occurs in the later stages of
adipogenesis.
Additionally, our data demonstrate that GR expression
is not regulated during adipogenesis, but the association
between GR and STAT5A is highly regulated during fat cell
differentiation and that inhibition of differentiation is ac-
companied by an inhibition in the STAT5A/GR interaction
(Fig. 6B). These results indicate that the association of
STAT5A and GR may be important in regulating adipocyte
gene expression, and future studies will focus on under-
standing this relationship. Furthermore, the effect of
TNF- on the association of STAT5A and GR suggests that
the interaction of these transcription factors in adipocytes
may play a role in insulin sensitivity. There is long-
standing evidence that GR in the nervous system affects
energy balance (29), but recent studies suggest that pe-
ripheral GR in adipose tissue also contributes to abdomi-
nal obesity (30). In particular, the effect of glucocorticoids
produced in adipose tissue has been examined in animal
studies. Transgenic mice overexpressing 11-hydroxy-
steroid dehydrogenase type I selectively in adipose tissue
exhibited pronounced insulin-resistant diabetes, hyperlip-
idemia, and hyperphagia (31). Taken together, these stud-
ies strongly suggest that there are GR-dependent pathways
in adipocytes that contribute to systemic biology.
In summary, our findings suggest that STAT5A and
STAT5B have nonredundant roles in adipogenesis and that
STAT5A, alone or in the presence of STAT5B, is adipo-
genic in nonprecursor cells. These findings support recent
studies demonstrating that STAT5 proteins are highly
regulated in adipocytes (5,7), that they have the ability to
influence adipogenesis (8,9), and that transgenic mice
lacking either STAT5 gene have a reduction in fat pad size
(4). Hence, it is not unexpected that STAT5A is adipogenic
in nonprecursor cells. However, GH, a potent STAT5A and
STAT5B activator, inhibits the expression of many adipo-
cyte genes such as fatty acid synthase and GLUT4 in fully
differentiated adipocytes (32). We predict that STAT5
proteins can exert both negative and positive effects on
adipocyte gene expression, perhaps via their association
with GR.
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